As an example, an 8-week weight loss intervention conducted with obese MetS participants resulted in changes in plasma MDA and plasminogen activator inhibitor-1 (PAI-1), but additionally did not show decreases in CRP and IL-6 [41]. This evidence concerns the gene SERPINE1 and metabolic syndrome.